首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Conjugation of Ibuprofen to Poly Ethylene Glycol and In-vitro drug release evaluation
【24h】

Conjugation of Ibuprofen to Poly Ethylene Glycol and In-vitro drug release evaluation

机译:布洛芬与聚乙二醇的结合及体外药物释放评价

获取原文
       

摘要

Polymers have become an integral part of drug delivery systems due to their improved pharmacokinetics properties. Polymer conjugation is a well-known and widely exploited technique useful to improve therapeutic properties of peptides, proteins, small molecules and oligonucleotides. Polymer conjugated drug generally exhibit prolonged half-life, higher stability, water solubility, lower immunogenicity, antigenicity and often also to the specific targeting tissue. Polymer materials are designed to be capable of delivering active substance. to the target diseased tissues and cells. Conjugation of Ibuprofen and polyethylene glycol (PEG) helps to increase the duration of action of the parent drug. The PEG-Ibu conjugates were synthesized from ibuprofen and PEG with two different molecular weights by esterification in the presence of DCC and DMAP. The PEG-Ibu conjugation characterized by FT-IR, UV, DSC and NMR and also in-vitro drug release study in different buffer at different ph.
机译:聚合物由于其改善的药代动力学特性而已成为药物递送系统的组成部分。聚合物结合是一种众所周知的且被广泛利用的技术,可用于改善肽,蛋白质,小分子和寡核苷酸的治疗性能。聚合物共轭药物通常表现出延长的半衰期,更高的稳定性,水溶性,更低的免疫原性,抗原性,并且通常还表现出对特定靶向组织的作用。聚合物材料被设计为能够输送活性物质。到目标患病的组织和细胞。布洛芬和聚乙二醇(PEG)的结合有助于增加母体药物的作用时间。在存在DCC和DMAP的情况下,通过酯化由具有两种不同分子量的布洛芬和PEG合成PEG-Ibu缀合物。以FT-IR,UV,DSC和NMR为特征的PEG-Ibu偶联以及在不同pH值的不同缓冲液中的体外药物释放研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号